Affiliation:
1. Wyeth Vaccines Research, Pearl River, New York 10965
Abstract
ABSTRACT
A novel antigen that induces cross-reactive bactericidal antibodies against a number of
Neisseria meningitidis
strains is described. This antigen, a ∼28-kDa lipoprotein called LP2086, was first observed within a complex mixture of soluble outer membrane proteins (sOMPs) following a series of fractionation, protein purification, and proteomics steps. Approximately 95 different neisserial isolates tested positive by Western blotting and PCR screening methods for the presence of the protein and the gene encoding LP2086. The strains tested included isolates of
N. meningitidis
serogroups A, B, C, W135, and Y,
Neisseria gonorrhoeae
, and
Neisseria lactamica
. To better understand the microheterogeneity of this protein, the 2086 genes from 63 neisserial isolates were sequenced. Two different subfamilies of LP2086 were identified based on deduced amino acid sequence homology. A high degree of amino acid sequence similarity exists within each 2086 subfamily. The highest degree of genetic diversity was seen between the two subfamilies which share approximately 60 to 75% homology at the nucleic acid level. Flow cytometry (fluorescence-activated cell sorting) analyses and electron microscopy indicated that the LP2086 is localized on the outer surface of
N. meningitidis
. Antiserum produced against a single protein variant was capable of eliciting bactericidal activity against strains expressing different serosubtype antigens. Combining one recombinant lipidated 2086 (rLP2086) variant from each subfamily with two rPorA variants elicited bactericidal activity against all strains tested. The rLP2086 family of antigens are candidates worthy of further vaccine development.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Immunology,Microbiology,Parasitology
Reference45 articles.
1. Abdillahi, H., and J. T. Poolman. 1987. Whole cell ELISA for typing Neisseria meningitidis with monoclonal antibodies. FEMS Microbiol. Lett.48:367-371.
2. Ashton, F. E., L. Mancino, A. J. Ryan, J. T. Poolman, H. Abdillahi, and W. D. Zollinger. 1991. Serotypes and subtypes of Neisseria meningitidis serogroup B strains associated with meningococcal disease in Canada, 1977-1989. Can. J. Microbiol.37:613-617.
3. Effect of lipopolysaccharide structure on reactivity of antiporin monoclonal antibodies with the bacterial cell surface
4. Bernfield, L., L. Fletcher, A. Howell, J. Farley, R. Zagursky, M. Knauf, and G. Zlotnick. 2002. Identification of a novel vaccine candidate for group B Neisseria meningitidis, p. 116. In D. A. Caugant and E. Wedege (ed.), Abstracts of the Thirteenth International Pathogenic Neisseria Conference. National Institute of Public Health, Oslo, Norway.
5. Bessler, W. G., and G. Jung. 1992. Synthetic lipopeptides as novel adjuvants. Res. Immunol.143:548-553.
Cited by
301 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献